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Abstract
One to two percent of all children are born with a developmental disorder requiring pediatric
hospital admissions. For many such syndromes, the molecular pathogenesis remains
poorly characterized. Parallel developmental disorders in other species could provide com-
plementary models for human rare diseases by uncovering new candidate genes, improv-
ing the understanding of the molecular mechanisms and opening possibilities for
therapeutic trials. We performed various experiments, e.g. combined genome-wide associ-
ation and next generation sequencing, to investigate the clinico-pathological features and
genetic causes of three developmental syndromes in dogs, including craniomandibular
osteopathy (CMO), a previously undescribed skeletal syndrome, and dental hypominerali-
zation, for which we identified pathogenic variants in the canine SLC37A2 (truncating splic-
ing enhancer variant), SCARF2 (truncating 2-bp deletion) and FAM20C (missense variant)
genes, respectively. CMO is a clinical equivalent to an infantile cortical hyperostosis (Caffey
disease), for which SLC37A2 is a new candidate gene. SLC37A2 is a poorly characterized
member of a glucose-phosphate transporter family without previous disease associations.
It is expressed in many tissues, including cells of the macrophage lineage, e.g. osteoclasts,
and suggests a disease mechanism, in which an impaired glucose homeostasis in osteo-
clasts compromises their function in the developing bone, leading to hyperostosis. Muta-
tions in SCARF2 and FAM20C have been associated with the human van den Ende-Gupta
and Raine syndromes that include numerous features similar to the affected dogs. Given
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the growing interest in the molecular characterization and treatment of human rare dis-
eases, our study presents three novel physiologically relevant models for further research
and therapy approaches, while providing the molecular identity for the canine conditions.
Author Summary
Rare developmental disorders make a major contribution to pediatric hospital admissions
and mortality. There is a growing interest in the development of therapeutics for these
conditions, but that requires understanding of the genetic cause and pathology. Research
can be facilitated by physiologically relevant models, such as dogs with corresponding dis-
orders. We have characterized the clinical features and genetic causes of three develop-
mental syndromes in dogs, including craniomandibular osteopathy (CMO), a previously
undescribed skeletal syndrome, and dental hypomineralization, for which we identified
mutations in the canine SLC37A2, SCARF2 and FAM20C genes, respectively. CMO is a
clinical equivalent to an infantile cortical hyperostosis (Caffey disease) for which SLC37A2
is a new candidate gene. SLC37A2 is a glucose-phosphate transporter in osteoclasts, and
its defect suggests an impaired glucose homeostasis in developing bone, leading to hyper-
ostosis. Mutations in the SCARF2 and FAM20C genes have been associated with the
human van den Ende-Gupta and Raine syndromes. Our study provides molecular identity
for the canine conditions and presents three novel physiologically relevant models of
human rare diseases.
Introduction
One to two percent of all children are born with a developmental disorder, such as a heart
defect, skeletal abnormality, or mental retardation as a result of errors in embryogenesis and
early neurodevelopment. These disorders make a major contribution to pediatric hospital
admissions and mortality [1]. Rare pediatric disorders are typically with homozygous, com-
pound heterozygous, or de novo pathogenic variants. The advent of cost-efficient next genera-
tion sequencing (NGS) technologies drives gene discovery in many disorders without a
cognate gene [2] and thousands of rare variants have been described (www.orpha.net). There is
also a growing interest in the development of therapeutics for rare diseases, which requires the
identification of the genetic defects, comprehensive understanding of the molecular pathology
and access to physiologically relevant animal models.
Developmental disorders are frequent also in other species, including dogs, which as large
animals bear very close physiologic and genetic resemblance with us. Dogs give birth to litters
with multiple puppies. However, often some of the littermates are affected by developmental or
other abnormalities, and perinatal mortality (stillbirth, fetal and neonatal death) is common
with prevalence ranging from 5 to 35% [3]. The causes include respiratory distress syndrome/
hypoxia, infectious diseases, severe malformations and suspected hereditary diseases. Culling is
a common practice among dog breeders and the deceased or abnormal puppies are not always
presented to the veterinarian. Therefore, numerous syndromes with likely genetic origin
remain unknown. It would be important to investigate the extent of this common phenomenon
at the clinical and molecular level to better understand the diverse causes of the morbidity and
to better manage it through advised breeding programs. At the same time, the identification of
the causative gene could inform gene functions, disease etiology, molecular pathology and
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phenotypic overlap across species. Importantly, physiological similarity of dogs with human
would establish relevant therapeutic models to human rare disorders. Online Mendelian Inher-
itance in Animals (OMIA), a catalogue of inherited disorders and associated genes in animals,
reports more than 350 inherited diseases in dogs as potential models for human disease (http://
omia.angis.org.au/).
NGS approaches are rapidly changing the diagnostic landscape in veterinary medicine in
companion animals and enable now a feasible approach to tackle the molecular background of
developmental conditions in small pedigrees with translational potential to human rare disease.
For example, we have previously discovered a new gene (ATG4D) responsible for a neurode-
generative vacuolar storage disease in Lagotto Romagnolos [4] and a missense variant in canine
FAM83G causing palmoplantar hyperkeratosis and demonstrating its role in maintaining the
integrity of the palmoplantar epidermis [5]. A CNGB1 frameshift variant has been identified to
cause a progressive retinal atrophy in dogs [6] and the same gene has been associated with reti-
nal degeneration in human as well [7]. Similarly, we have found that a congenital skeletal dis-
ease in Brazilian Terriers is caused by a pathogenic variant in the GUSB orthologue responsible
for human pediatric disorder, mucopolysaccharidosis type VII [8].
This study addressed the clinical and genetic background of three developmental disorders
in dogs; craniomandibular osteopathy (CMO; OMIA: 000236–9615) in West Highland White
Terriers (WHWT), Cairn Terriers and Scottish Terriers, a previously undescribed developmen-
tal syndrome inWire Fox Terriers, and dental hypomineralization in Border Collies. CMO is a
self-limiting proliferative bone disease seen in young dogs [9]. It manifests between 4 to 8 months
of age with typical signs including swelling of the jaw, periodical fever, lack of appetite, pain, diffi-
culty opening the mouth and dysphagia. The excessive proliferation causes bony lesions primar-
ily on the skull bones, especially on the mandible and tympanic bulla, but occasionally also on
the metaphyses of long bones. Signs of the disease usually resolve with time, when the growth
period is finished. CMO exists in several breeds with the highest frequency inWHWT and has
been suggested to be an autosomal recessive trait [10–12]. Canine CMO corresponds to human
Caffey disease [MIM: 114000] and its genetic characterization might reveal insights into similar
painful human swelling disorders [10]. We identified a novel CMO gene that represents a candi-
date gene for human Caffey disease. The two other syndromes have not previously been reported
in dogs. We describe the detailed clinical features for them in our study. Moreover, we demon-
strate their shared genetic etiology with the corresponding human syndromes, van den Ende-
Gupta (VDEGS [MIM: 600920]) and Raine syndromes [MIM: 259775].
Results
A splicing variant in SLC37A2 causes craniomandibular osteopathy in
three terrier breeds
We performed a genome-wide association study (GWAS) to map the CMO locus with Illumi-
na’s 22K canine SNP chips in a cohort of 51 WHWTs, including 10 cases (diagnosed by ra-
diography; Fig 1A) and 41 controls. A case-control association test revealed significant
association on CFA5 with the best SNP (BICF2S23544899) at 8,953,507 Mb (praw = 1.2 x 10
−7,
pgenome = 0.02) (genomic inflation factor λ = 1.17) (Fig 1B). Manual assessment of genotypes
at the CFA5 locus revealed a shared 1.9-Mb homozygosity block in all affected dogs spanning
from 7,764,955 bp to 9,707,794 bp. The same homozygosity block was seen in five controls as
well. The associated region was replicated and fine-mapped using 105 additional SNPs in 88
samples from three related breeds, WHWT, Cairn Terriers and Scottish Terriers. Fine mapping
confirmed the association in all three breeds with the best SNP BICF2S23134295 at 8,183,669
(p = 2.09x10-15).
Three Canine Models of Human Rare Bone Diseases
PLOS Genetics | DOI:10.1371/journal.pgen.1006037 May 17, 2016 3 / 20
Fig 1. Genetic analyses in canine craniomandibular osteopathy identify a leaky splicing variant in exon 15 of SLC37A2, resulting in a frameshift
that truncates the protein. A. Laterolateral (left) and ventrodorsal (right) radiograph of the skull of two different WHWT affected with CMO. The typical
palisade-like periosteal new bone formation is commonly located along the corpus mandibulae (left, white arrowheads) or around the Bulla tympanica
(right, black arrowheads). B.Manhattan plot from GWAS indicates the associated region on chromosome 5 (pgenome = 0.02).C. A synonymous variant, c.
1332C>T, in exon 15 of SLC37A2. D. ESEfinder suggests that the synonymous variant affects a splicing enhancer site. The binding scores for the
different splicing factors (colored blocks) for 79 nucleotides of exon 15 are shown for the wild-type and mutant allele. The c.1332C>T mutation eliminates
a potential binding site for the SF2/ASF splicing factor (shown in purple). Binding scores for different splicing proteins (shown on the y-axis) are based on
different weight matrices and cannot be compared directly to each other. E. A semi-quantitative RT-PCR in the wild-type (CC), carrier (CT) and affected
(TT) WHWTs confirms the splicing defect (79 bp deletion) caused by the variant, and reveals a splicing leakage in the carrier and affected dogs. B2Mwas
used as a loading control. F. A schematic 12-transmembrane secondary structure of SLC37A2 predicted by TMHMM. The truncated region in the
mutated protein is indicated by a dashed line.
doi:10.1371/journal.pgen.1006037.g001
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To identify candidate variants, the associated and fine mapped region (1.8 Mb) was cap-
tured from two affected and two healthy WHWT with opposite haplotypes followed by a
paired-end NGS by HiSeq2000. The shared variants identified in the two affected WHWT
dogs were filtered against the two WHWT controls and 32 additional healthy dogs from four
different breeds. We found altogether three homozygous variants shared in cases (S1 Table);
two intergenic indels and a synonymous variant in exon 15 of solute carrier family 37 member
2 gene (SLC37A2 c.1332 C>T) (Fig 1C). As an additional independent verification to avoid
potential targeted capture biases, we performed whole genome sequencing in one CMO-
affected WHWT and 188 control dogs from other breeds (S2 Table) to compare the variants in
the associating region. This analysis yielded a single case-specific variant (chr5
g.9,387,327G>A) that was the same as the one identified in the capture experiment.
Although the variant, c.1332C>T in exon 15 of SLC37A2 is synonymous, it was predicted
to affect a splicing enhancer element based on ESEfinder analysis (Fig 1D). The mutant T allele
eliminates a potential binding site for the splicing factor ASF/SF-2. To confirm the predicted
effect on splicing, we amplified the region between exons 7 and 18 in lymphocyte mRNAs
from three cases, six carriers and seven controls. RT-PCR experiments showed that two alter-
natively spliced SLC37A2 transcripts were expressed in all dogs that carried one or two copies
of the mutant T allele at the SLC37A2 SNP, regardless of disease status (Fig 1E). Sequencing of
the RT-PCR products indicated that the smaller band corresponded to a mutant SLC37A2
transcript lacking 79 bp from exon 15. The splice variant resulted in a frameshift and prema-
ture stop codon at the beginning of exon 16. This altered splicing was predicted to lead to a C-
terminally truncated protein lacking 75 amino acids compared to the wild-type SLC37A2 pro-
tein (Fig 1F). The RT-PCR indicated that both wild-type and mutant transcripts were
expressed in even the CMO affected dogs, although the expression of the wild-type transcript
was significantly reduced in the affected homozygous dogs (Fig 1E). The reduction of the wild
type transcript level was more moderate in healthy heterozygous carrier dogs. None of the
examined wild-type dogs expressed the mutant transcript. Overall, these results demonstrate
the leaky nature of the splice site mutation.
To investigate the segregation and frequency of the variant across the CMO affected breeds,
we performed a large variant screening by genotyping the c.1332C>T variant altogether in
1052 dogs, including 695 WHWT, 249 Scottish Terriers and 108 Cairn Terriers (S3 Table). We
found 123 homozygous dogs in the WHWT breed, of which 48% had been reported with
CMO. About 40% of WHWT (275 dogs) carried the pathogenic variant, of which 10 dogs
(3,6%) were reported with CMO. In Scottish Terriers, 10 dogs (4%) were homozygous and all
were reported with CMO, and 43 dogs (17%) were carriers, of which 3 dogs (7%) were reported
with CMO. In Cairn Terriers, 9 dogs (8%) were homozygous and reported with CMO, and 15
dogs (14%) carried the pathogenic variant, from which 3 dogs (20%) were reported with CMO.
We found one wild-type dog in both Scottish and Cairn Terriers with CMO, and screened the
coding regions of the entire SLC37A2 gene in these two dogs for possible other pathogenic vari-
ants, but did not find any. This suggests phenocopies, misdiagnoses or genetic heterogeneity.
The analysis of the pathogenic variant in the three main breeds with 96 cases resulted in a
highly significant association (p = 6.62x10-303) with CMO.
In addition to the above three breeds, we screened the c.1332C>T variant in 458 dogs in
124 breeds, but found only a single heterozygous carrier dog in Jack Russell Terrier breed (S3
Table). The phenotype information for this dog was not available. The variant was also
screened in the known CMO cases from seven breeds (two Bull Terriers, one Curly Coated
Retriever, two Border Collies, one Australian Terrier, one Basset, one German Wirehaired
Pointer, one Old English Sheepdog), but they did not have it.
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Collectively, our results suggest that CMO is inherited as dominant disease with incomplete
penetrance. Canine CMO is equivalent to Caffey disease and our data reveals a novel candidate
gene, SLC37A2, for the syndrome.
Truncated SCARF2 causes a skeletal syndrome in Wire Fox Terriers
Wire Fox Terrier breeders contacted us for help in the characterization of an unknown congen-
ital syndrome with severe mandibular prognathia and other skeletal features, mainly severe
patellar luxation, in the breed. Two affected 7-week-old puppies from different litters, two
unaffected littermates and two affected adult Wire Fox Terriers were examined by radiography.
Additionally, a computed tomography (CT) study of the skull was made on two affected dogs
(one adult and one puppy), and three dogs were studied for general clinical characteristics and
neurological examination.
A prominent underbite with short maxilla (brachygnathia superior) was evident in all
affected Wire Fox Terriers except one adult dog (Fig 2A and 2B). The caudodorsal border of
the maxilla was slightly convex in all affected animals. In CT images, the nasal septum deviated
prominently to the left at the level of the dorsocaudal frontal bone in both examined dogs (Fig
2C). The number and position of the vertebrae were normal, but the mid-thoracic spinous pro-
cesses were thinner, longer and more horizontally aligned in the affected than in the normal
dogs. One adult dog had an abnormally wide second rib. The adult dog had marked spondylo-
sis of the spine. One affected puppy had unilateral congenital elbow luxation (Fig 2D), and in
the other the secondary ossification centers of the olecranon were non-mineralized. The sec-
ondary ossification centers of the tibial tuberosities were small in both affected puppies, when
compared to a healthy puppy (Fig 2E and 2F). The proximal epiphyses of the fibulae were not
mineralized in the affected puppies and the patellae were medially luxated. The femurs of the
affected dogs had medial bowing of mid-shafts of the bone. In an eye examination of a puppy
and two affected adult dogs, the eyes appeared small and the sclera thinner than normal.
Clinical examination of three affected dogs indicated swollen knee joints and patellar luxa-
tion. Neurologically, all the examined dogs were alert and exhibited no remarkable neurological
deficits. Postmortem examination of two puppies (one newborn and one 7 weeks old) did not
reveal any additional gross abnormalities.
To identify the genetic cause of the syndrome, we performed GWAS with Illumina’s Cani-
neHD array in a cohort of 12 Wire Fox Terriers including 4 cases and 8 controls. A case-con-
trol association test revealed association on chromosome 26 with seven nearby SNPs at
29,607,333 to 31,863,083 Mb (praw = 7.74x10
-6, pgenome = 0.05) (genomic inflation factor λ =
1.10) (Fig 3A). Manual assessment of genotypes at the CFA5 locus revealed a shared homozy-
gosity segment of ~3 Mb in the affected dogs spanning from 29,176,909 to 32,226,403 bp (Fig
3B). The associated region was captured and resequenced from five samples including two
affected, two healthy and one obligate carrier Wire Fox Terrier (S4 Table). We identified a
2-bp homozygous deletion in exon 6 of the SCARF2 gene in the affected dogs after filtering the
data according to an autosomal recessive model and against additional 169 unaffected control
dogs from different breeds (S2 Table). The identified SCARF2 c.865_866delTC variant results
in a frameshift and a premature stop codon, (p.S289Gfs15), leading to a truncated protein in
the first half of the coding region (Fig 3C).
Screening of the variant within the Wire Fox Terrier breed (57 dogs) confirmed full segrega-
tion with the disease (S5 Table). The four cases from the GWA study and an additional case
were homozygous for the variant, while obligate carriers were heterozygous. The larger screen-
ing for the mutation revealed one homozygous dog that was a littermate of one of the geno-
typed affected dogs. This dog was then clinically examined, including neurological
Three Canine Models of Human Rare Bone Diseases
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examination, radiography and CT scanning. The clinical findings confirmed the disease,
including mandibular prognathia and patellar luxation. The carrier frequency among the pop-
ulation controls (n = 45) was 22%.
The effect of the 2-bp deletion on the stability of the SCARF2mRNA was investigated by
RT-PCR in postmortem skin samples from one affected and one unaffected dog (Fig 3D). The
SCARF2mRNA was detected both in affected and unaffected samples suggesting that the
mutated transcript is not affected by nonsense-mediated RNA decay in the studied tissue.
SCARF2 defects have been reported in the rare human bone disease van den Ende-Gupta
syndrome. Our results thus established an orthologous canine model with clinical similarity.
Fig 2. Radiographic and CT findings in a novel canine developmental syndrome. A. Lateral radiograph
of a 7-week-old affectedWire Fox Terrier puppy, where prominent underbite (long arrow) and dorsally convex
maxilla (short arrow) are clearly visible.B. Healthy littermate with normal scissor bite and flat dorsal border of
the maxilla.C. Transverse CT image of the nasal cavities of an affected puppy. Marked lateral deviation of the
nasal septum is evident (arrow).D. Lateral radiograph of stifle joints of an affected puppy. The ossification
centers are poorly mineralized (long arrows) and the proximal fibular epiphyses are non-mineralized (short
arrows). E. Lateral image of an unaffected puppy indicates that the ossification centers are normal for the age
(long arrows) and proximal epiphysis of the fibula is clearly seen (short arrow). F. Ventrodorsal radiograph of
an affected puppy. Lateral luxation of the left radial head is evident.
doi:10.1371/journal.pgen.1006037.g002
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Amissense variant in FAM20C causes dental hypomineralization in
Border Collies
We were approached by a Border Collie breeder with a family of several affected dogs that suf-
fered from severe tooth wear resulting in pulpitis and requiring extraction of those teeth. Fur-
ther inspection of the tooth problem in the breed identified additional related cases, suggesting
an autosomal recessive mode of inheritance (S1 Fig). Two affected dogs were subjected to a
clinical study, including dental examination and radiography, as well as to histology of the
Fig 3. Genetic analyses in a developmental syndrome inWire Fox Terriers reveal a deletion in exon 6
of SCARF2, resulting in an early truncation of the predicted protein. A. A Manhattan plot from a GWAS
indicates a locus on chromosome 26 (pgenome = 0.05). B. A 3.3-Mb disease-associated haplotype in the
affected dogs. C. Targeted resequencing revealed a 2-bp deletion in exon 6 (c.865-866delTC), resulting in a
severe truncation at Ser289 that removes the transmembrane and cytoplasmic domains of the predicted
protein as indicated by a dashed line in the schematic structure.D. RT-PCR in the affected and control Wire
Fox Terrier indicate expression of SCARF2mRNA and suggest that the mutated SCARF2 transcript is not
directed to nonsense-mediated RNA decay.
doi:10.1371/journal.pgen.1006037.g003
Three Canine Models of Human Rare Bone Diseases
PLOS Genetics | DOI:10.1371/journal.pgen.1006037 May 17, 2016 8 / 20
extracted teeth and were regularly followed up in the next years. In addition, dental radio-
graphs were available from two other cases.
Dental examination of a neutered 9-year-old female Border Collie revealed that all remain-
ing teeth had significant wear. The previous dental treatment was performed 2 years earlier
and multiple teeth were extracted. The length of the crowns was reduced. Lower incisor teeth
were worn close to gingival margin. The enamel appeared dull and had light brown discolor-
ation. The worn occlusal surfaces were discolored dark brown and there was reparative dentin
formation. There were five teeth that had pulp exposure and pulpitis as a result of the wear
(Fig 4A). The dog’s occlusion was normal and, therefore, the dental wear was not caused by
abnormal tooth-to-tooth contact (attrition). Calcitriol (1,25(OH)2D3), phosphate and alkaline
phosphatase levels in blood were normal. The other dental examination was performed for a
neutered 10-year-old male Border Collie, revealing similar findings (Fig 4B and 4C). Other
external causes such as abrasive hard chews were excluded as a cause of dental wear in both
affected dogs.
Extracted teeth from two affected dogs, a 9-year-old female Border Collie described above
and its female littermate, were submitted to histopathological examinations. The analysis of
ground sections did not reveal structural aberrations but the enamel of the incisor was smooth
and slightly hypoplastic as compared to the unaffected control dog (Fig 4D and 4E). The
enamel of the premolar had largely worn and cracked, but the cervical enamel, which was pre-
served, showed no structural defects. Coronal dentin of both teeth comprised three distinct, cir-
cumferential zones. The tubular pattern and the structure of the matrix in the thick peripheral
zone subjacent to the enamel were regular. The middlemost zone was pronouncedly globular
(Fig 4E and 4F). The neighboring globules largely adapted to each other and the tubules ran
Fig 4. The dental phenotype in the Border Collies with a homozygous FAM20C variant. A. X-ray of the anterior mandibular teeth of a 9-year-old female
Border Collie. Arrows indicate apical inflammations. B. X-ray of the anterior mandibular molars and premolars of a 10 year old male Border Collie indicating
dental wear and apical inflammations (arrows). C. Anterior mandibular molars and premolars of the same dog indicating dental wear causing pulpal
exposure. D.Ground section of a deciduous incisor from an unaffected Border Collie showing intact enamel and normal dentin, the crack is artefactual. E.
Ground section of a permanent incisor of an affected 9-year-old female Border Collie. The enamel layer (e) preserved cervically is thin as compared to the
control tooth (D). Wear at the edge (arrow) of tooth extends to the peripheral regular dentin (rd) and deeper to the abnormal globular dentin (gd), not present
in the control (D). F.Ground section from deeper position of the same tooth as in (E) showing the layerwise alteration in the dentin structure. Peripheral dentin
(rd) has a normal tubular pattern with no globules, the middlemost zone is pronouncedly globular (gd), while the central zone (cd) next to the diminished or
almost completely obliterated pulp chamber (p) shows a slightly irregular tubular pattern but no globules.G.Haematoxylin-eosin stained paraffin section
of a premolar from a 9-year old female. Contiguous interglobular spaces (arrows) in the middlemost dentin zone stain lightly with eosin. Tubules run
uninterruptedly in stained areas. Bars, 50 um (D,E,F) and 200 um (G).
doi:10.1371/journal.pgen.1006037.g004
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uninterrupted. Wider interglobular spaces were filled with air. The globules diminished and
disappeared in the central direction. The central dentin zone next to the reduced pulp showed
no matrix defects, but the tubular pattern was slightly irregular (Fig 4F). The proportion of
globular dentin gradually reduced in the apical direction.
The analysis of paraffin sections demonstrated significant wear of the dentin. The structure
of the peripheral zone was regular, whereas the middlemost zone was globular. Between the
globules there were wide, contiguous defects with an angular contour, void of matrix and
tubules and filled with amorphous, barely detectable material (Fig 4G). A pulp chamber did
not become visible at the level of the sections. Tubules in the central dentin zone were slightly
irregular. Pulp tissue in the root canal was necrotic. A patchy, chronic inflammatory cell infil-
trate with plasma cells predominating was present apically. The structure of the acellular
cementum was regular. Lacunae in the cellular cementum and at the periphery of the alveolar
bone trabeculae were in places obliterated. Demarcated areas in the periodontal ligament facing
the alveolar bone showed an amorphous, fibrotic texture. Overall, clinical and histopatholog-
ical analyses indicate severe hypomineralization of teeth in the affected dogs.
To identify the cause of the mineralization defect we sequenced the whole genomes of three
affected dogs. The variants of the affected dogs were filtered against two unaffected obligate
carriers and fourteen other unaffected Border Collie genomes assuming recessive transmission,
resulting in the identification of a case-specific non-synonymous homozygous variant,
c.899C>T, in the FAM20C gene. This leads to a missense change, p.A300V, in a highly con-
served position in the kinase domain of the FAM20C protein (Fig 5). Bioinformatic predictions
by SIFT (with a score of 0.00) and Polyphen2 (with a HumVar score of 0.992) suggested patho-
genicity. Genotyping the pedigree and additional Border Collies (191 dogs) demonstrated com-
plete segregation of the variant with the disease phenotype (S1 Fig and S6 Table) and showed
11% carrier frequency in the breed. We also genotyped 186 dogs from 20 additional breeds (S6
Fig 5. Whole genome sequencing of three Border Collies affected with tooth attrition reveals a
missense variant, FAM20C c.899C>T, in the conserved kinase domain of the protein (p.A300V).
doi:10.1371/journal.pgen.1006037.g005
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Table), but did not find any carriers in the other breeds suggesting that this pathogenic variant
is specific for Border Collies.
Defects in FAM20C have been associated with a rare human disease, Raine syndrome/
FGF23-related hypophosphatemia characterized by dental and bone hypomineralization. Our
results indicated a causative variant in the kinase domain of FAM20C and established a canine
model for human Raine syndrome.
Discussion
This study demonstrates the power of NGS approaches to establish molecular diagnosis and
categorization for unknown congenital canine disorders with high relevance to rare human dis-
eases. We identified a novel candidate gene, SLC37A2, for the corresponding human disease,
infantile cortical hyperostosis, also known as Caffey disease, and implicated SCARF2 and
FAM20C variants in the canine forms of van den Ende-Gupta and Raine syndromes, respec-
tively. All three spontaneous canine models closely resemble the human syndromes and pro-
vide physiologically relevant models to better understand poorly characterized gene functions
in each condition and the entire molecular pathologies. Given the growing interest in the devel-
opment of new therapies for rare human diseases, our study highlights the fact that dogs carry
clinically and genetically close counterparts of rare human diseases that could be better utilized
to advance molecular research and to develop efficient preclinical trials in large animals with
spontaneous diseases [13, 14]. Many human rare disease models exist in dogs, and encouraging
private pet owners to participate in clinical trials could facilitate the validation of human treat-
ment approaches, while also benefitting canine health.
Identification of the canine CMO variant implicates a sugar-phosphate
transporter in hyperostosis
Our study unraveled a physiological function of SLC37A2 and provided new insights into
infantile swelling diseases, which may be related to disturbances in the intracellular glucose
homeostasis during bone development. We identified an unusual leaky splicing defect in the
SLC37A2 gene in CMO-affected dogs. CMO is a self-limiting hyperostosis in multiple bones in
young dogs. The most prominent sign in the affected puppies included painful swelling of the
jaw, leading to dysphagia and difficulty in opening the mouth. CMO is clinically equivalent to
human infantile cortical hyperostosis [10, 15]. A common missense variant in COL1A1 has
been found in several patients with an autosomal dominant condition with incomplete pene-
trance [16, 17]. Interestingly, the mechanism how the defected collagen leads to self-limiting
hyperostotic bone lesions is still unknown. Early molecular diagnosis of Caffey patients would
avoid invasive procedures, however, the molecular etiology remains unknown in many cases.
SLC37A2 represents a new functional candidate gene. It belongs to the SLC37 family of four
ER-associated glucose-phosphate transporters [18]. SLC37A2 is ubiquitously expressed, but
transcript and protein levels are particularly high in bone-related tissues such as bone marrow
and hematopoietic cell linages such as osteoclasts and macrophages [19, 20]. Murine Slc37a2
was shown to be one of the genes strongly involved in the osteoclast differentiation, suggesting
that it plays a role in osteoclast function and differentiation [20]. Therefore, SLC37A2 may
play a central role in glucose homeostasis in the key cell types that participate in osteogenesis.
For example, an impaired function of SLC37A2 due to a truncating splice variant might disturb
proper glucose supply in the osteoclasts, decreasing their overall activity, which in turn would
result in an imbalance between osteoblastic and osteoclastic functions in the developing bones
eventually leading to hyperostosis. Defects in SLC37A4, glucose-6-phosphate transporter
(G6PT), have been associated with glycogen storage disease 1b and 1c, characterized by
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recurrent infections and neutropenia due to disturbed blood glucose metabolism [21–23]. Our
results link SLC37A2 to bone physiology and disease, and we propose SLC37A2 as an excellent
candidate for genetic screening in Caffey patients. Meanwhile, the affected dogs provide unique
resources for future experiments to address SLC37A2-related mechanisms in osteogenesis biol-
ogy. A recent study in hematopoietic cells identified SLC37A2 as a primary vitamin D target
with a conserved vitamin D receptor-binding site [24]. This may open investigations to study
the opportunity to use vitamin D as a therapeutic booster to regulate diminished expression of
wild type expression of SLC37A2 in the affected dogs to alleviate clinical signs.
Caffey disease is an autosomal dominant disease with incomplete penetrance, although rare
cases of recessively inherited Caffey disease have also been reported [25]. Corresponding
canine diseases exist in several terrier breeds with the highest frequency in West Highland
White Terriers. The determination of the exact mode of inheritance in dogs is not straightfor-
ward due to the nature of the leaky splice variant and mild self-limiting phenotype that may
remain unobserved and prevent retrospective diagnosis. We found some dogs that were homo-
zygous for the variant but had no reported clinical signs. However, we observed a considerable
level of the wild-type SLC37A2 transcript in homozygous dogs in the peripheral blood due to
the splicing leakage, suggesting that the leaky expression is sufficient to avoid a clinical pheno-
type in some cases. We also found several heterozygous dogs that had developed CMO. We
found that heterozygous dogs had lower levels of wild-type SLC37A2 transcript compared to
the unaffected dogs with individual variation of expression between dogs. This result suggested
a dominant disease with incomplete penetrance that could help to explain the reported differ-
ences in the severity and duration of CMO among the affected dogs, although alternative mod-
els of inheritance cannot be completely ruled out yet. The dominant phenotype could be due to
a dominant-negative effect, but this hypothesis requires further experimental validation to bet-
ter understand the details of the gene, its regulation and protein function, including potential
pairing with other proteins as described for SLC37A4/G6Pase complexes [18]. The in vivo
function of SLC37A4 has been shown to depend upon its ability to couple functionally with
either G6Pase-a or G6Pase-b [18, 26].
A SCARF2 truncation in a canine model of van den Ende-Gupta
syndrome
We identified a 2-bp deletion in SCARF2 in dogs with severe mandibular prognathia and other
skeletal abnormalities and established a canine model for van den Ende-Gupta syndrome
(VDEGS). VDEGS is a very rare disease with less than 30 reported cases [27]. It is characterized
by a heterogeneous variety of craniofacial and skeletal abnormalities including blepharophimosis,
a flat and wide nasal bridge, narrow and beaked nose, hypoplastic maxilla with or without cleft
palate and everted lower lip, prominent deformed ears, down-slanting eyes, arachnodactyly, and
camptodactyly. Patients may present congenital joint contractures that improve without inter-
vention, and have normal growth and development. Enlarged cerebellum is an infrequent finding
yet intelligence is normal. Some patients experience respiratory problems due to laryngeal abnor-
malities. Human and canine VDEGS patients share many similarities including hypoplastic max-
illa, dislocated radial head, patellar dislocation, and deviated nasal septum. Both have small eyes.
It remains unknown how the loss of function of SCARF2 leads to VDEGS. SCARF2 is a
poorly characterized member of the scavenger receptor type F family [28]. Besides epidermis,
Scarf2 is expressed in branchial arches, mandible, maxilla and urogenital ridge tissue of devel-
oping mouse embryos [29, 30]. It is a single-pass transmembrane protein with homology to
calmodulin (CaM)-like Ca2+-binding protein genes. The extracellular domain contains several
putative epidermal growth factor-like (EGF) domains, and it has a number of positively charged
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residues within the intracellular domain, suggesting a role in intracellular signaling. The 2-bp
deletion of the canine SCARF2 gene in one of the extracellular EGF domains leads to a severely
truncated protein that completely lacks the transmembrane and intracellular domains. The lack
of a transgenic mouse model and scarcity of human patients highlight the role of affected dogs as
a novel resource to understand SCARF2 functions and molecular pathology. As some of the
affected dogs survive past 10 years, they could potentially serve also as preclinical models.
Amissense variant in FAM20C identifies a canine model of Raine
syndrome
Whole genome sequencing of a family of several affected dogs that suffered from a severe den-
tal wear and loss of teeth revealed a recessive missense variant in the kinase domain of the
FAM20C gene. FAM20C defects cause autosomal recessive osteosclerotic bone dysplasia (Raine
syndrome) in humans. This rare syndrome with less than 40 reported cases was originally
described to be neonatal lethal, but recently there have been several reports of cases surviving
into childhood with variable severity and clinical heterogeneity [31–38]. Typical characteristics
in Raine syndrome include craniofacial anomalies, such as exophthalmos, abnormal and hypo-
mineralized teeth, midface hypoplasia, microcephaly and cleft palate, as well as gingival hyper-
plasia, generalized osteosclerosis and intracerebral calcifications. Variable extent of
hypophosphatemia has been observed, sometimes as the primary diagnosis [32, 35, 38]. Canine
findings in our cohorts were more limited to severe hypomineralization of teeth, leading to
extensive wear and inflammation as prominent features. We did not observe some of the typi-
cal gross changes described in Raine patients such as hypophosphatemia and craniofacial
anomalies. However, there is a significant clinical heterogeneity in the symptoms between
human patients and more detailed radiographic analyses should be performed in dogs to
observe potential mild changes outside the dental phenotype.
FAM20C is a Golgi casein kinase that phosphorylates secretory proteins such as FGF23 and
SIBLING (Small Integrin-Binding Ligand, N-linked Glycoprotein) family [39, 40]. Fam20c is sig-
nificantly expressed in mouse teeth and bone and transgenic mice studies have indicated a role in
differentiation and mineralization of odontoblasts, ameloblasts, osteoblasts and osteocytes during
tooth and bone development. FAM20C-deficient mice also have a prominent dental phenotype
[41–43]. Ablation of the Fam20c gene in conditional knockout mice affects tooth and bone devel-
opment by downregulation of SIBLING family of proteins such as DMP1 and DSPP and by
increasing FGF23 in serum and promoting phosphate excretion and hypophosphatemia [44].
Our FAM20C-deficient dogs have a dental phenotype similar to mice and humans and provide a
new research and preclinical model for this rare human bone disease. Unlike rodents, dogs have
dental physiology similar to human, having both deciduous and permanent dentition.
In summary, we describe here the clinical and genetic characteristics of three new canine
models for rare human bone disorders. While highlighting clinical and genetic similarities
between canine and human conditions, our study have several implications; it indicates new
physiological functions for the identified genes and provides new candidate genes to rare
human diseases, establishes potential preclinical models, and finally enables the development
of genetic tests for veterinary diagnostics and breeding purposes.
Materials and Methods
Ethics statement
Sample collection in Finland was ethically approved by the Animal Ethics Committee of State
Provincial Office of Southern Finland (Finland, ESAVI/6054/04.10.03/ 2012). The collection of
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blood samples in Switzerland was approved by the “Cantonal Committee For Animal Experi-
ments” (Canton of Bern; permit 23/10).
Study cohorts
EDTA-blood and tissue samples were collected from privately owned dogs in Finland, US and
Switzerland. The samples were stored at -20°C until genomic DNA was extracted using the
semi-automated Chemagen extraction robot (PerkinElmer Chemagen Technologie GmbH).
DNA concentration was determined either with the NanoDrop ND-1000 UV/Vis Spectropho-
tometer or Qubit 3.0 Fluorometer (Thermo Fisher Scientific Inc.). Pedigrees were drawn by the
GenoPro genealogy software (http://www.genopro.com/), and utilizing the public dog registry
by the Finnish Kennel Club (http://jalostus.kennelliitto.fi).
Clinical examinations for each condition are described in detail in the results section. CMO
cases were diagnosed by radiography by local veterinarians. The developmental disorder in
Wire Fox Terriers was investigated by radiography and CT. Neurological examination was per-
formed for three and ophthalmoscopy for two of the affected dogs. A specialized dental veteri-
narian examined two of the affected Border Collies with dental hypomineralization, while the
others were examined by local veterinarians. Clinical phenotype information was not available
for dogs used as population controls.
Genome-wide association study and fine mapping
Genome-wide association studies were performed in the CMO and VDEGS projects. For
CMO, altogether 51 dogs including 10 affected and 41 control dogs, were genotyped using Illu-
mina’s CanineSNP20 BeadChip of 22,362 validated SNPs. For VDEGS, a total of 15 dogs
including 4 affected and 11 unaffected Wire Fox Terriers, were genotyped using Illumina’s HD
array. The genotype data in both projects was filtered with a SNP call rate of>95%, array call
rate of>95% and minor allele frequency of>5%. No individual dogs were removed for low
genotyping and no SNPs were removed because of significant deviations from the Hardy-
Weinberg equilibrium (p 0.0001). After frequency and genotyping pruning, 14,835 and
69,694 SNPs remained for analyses for CMO and VDEGS data, respectively. Basic case-control
association test was performed by PLINK [45]. Genome-wide significance was ascertained with
phenotype permutation testing (n = 10,000 for CMO and n = 100,000 for VDEGS). Fine map-
ping of the identified CMO locus was performed with 105 selected SNPs from a 1.9-Mb region
(7,764,955–9,707,794 bp) on CFA5 (based on CanFam3.1). The SNPs were selected using
Broad Institute SNP collection CanFam2.0. Genotyping was performed using the Sequenom
(San Diego, CA, USA) iPLEX methodology at our local core facility in the FIMM Technology
Centre, University of Helsinki, Finland. A total of 88 samples were genotyped including 8 cases
and 8 controls in Cairn Terriers, 9 cases and 8 controls in Scottish Terriers and 29 cases and 26
controls in WHWTs. Association analysis was performed with PLINK using a single-marker
association analysis.
Targeted capture and resequencing
We performed a targeted sequence capture and next generation sequencing to identify the
pathogenic variants. We used NimbleGen’s in-solution capture technology to enrich the target
regions for sequencing (Roche NimbleGen, Madison, WI, USA). We captured 1.8-Mb region
of CMO associated locus at position CFA5: 10,750,000–12,550,000 using twoWHWT cases
and controls with opposite haplotypes. The haplotypes were assessed manually using SNP
genotype data. The same targeting experiment also contained samples from our other targeting
projects including 8 Border Terriers, 12 Duck Tolling Retrievers, 8 Schipperkes and 4 Brazilian
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Terriers and these samples were used as additional controls. For target enrichment and
sequencing of associated locus in Wire Fox Terriers, we captured a 3.3-Mb region at CFA26:
29,030,700–32,328,700 using two affected and two controls with opposite haplotypes and one
obligate carrier. The filtered case-specific variants were further checked from 169 additional
dogs in our variant database. Probes in the target regions were designed by Roche NimbleGen
(Roche NimbleGen). Target enrichment, alignment and variant calling pipeline were per-
formed as previously described [8]. Further data analysis was performed using open source R
language and environment (http://www.r-project.org). Canine genome build CanFam3.1 was
used as a reference sequence.
Whole genome sequencing
The genetic causes of CMO inWHWTs and tooth attrition in Border Collies were studied by
whole genome sequencing. In the CMO study, we performed whole genome sequencing of one
affectedWHWT dog and used 188 other available whole genomes as controls (S2 Table). A frag-
ment library was prepared with a 290 bp insert size and collected a single lane of Illumina
HiSeq2000 paired-end reads (2 x 100 bp). The reads were mapped to the dog reference genome
using the Burrows-Wheeler Aligner (BWA) version 0.5.9-r16 with default settings. The Picard
tools (http://sourceforge.net/projects/picard/) were used to sort the mapped reads by the sequence
coordinates and to label the PCR duplicates. The Genome Analysis Tool Kit (GATK version
v2.3–6) was used to perform local realignment and to produce a cleaned BAM file. Variant calls
were then made using the unified genotyper module of GATK. Variant data was obtained in vari-
ant call format (version 4.0) as raw calls for all samples and sites flagged using the variant filtration
module of GATK. Variant calls that failed to pass the following filters were labeled accordingly in
the call set: (i) Hard to Validate MQ0 4 & ((MQ0 / (1.0  DP))> 0.1); (ii) strand bias (low
Quality scores) QUAL< 30.0 || (Quality by depth) QD< 5.0 || (homopolymer runs) HRun> 5
|| (strand bias) SB> 0.00; (iii) SNP cluster window size 10. The SnpEff software together with the
CanFam 3.1 annotation was used to predict the functional effects of detected variants. In addition
to the SNP and short indel variant calling, large deletions contained in the candidate region were
searched by visual inspection of the BAM file using the Integrative Genomics Viewer (IGV). In
the Border Collie study, we whole genome sequenced altogether nineteen dogs, including three
affected dogs, two carriers and fourteen unaffected Border Collies, in the Science for Life Labora-
tory in Stockholm, Sweden. The reads were processed using speedseq align module available in
SpeedSeq suite to produce a duplicate-marked, sorted and indexed BAM file. The Genome Analy-
sis Tool kit (version = 3.3.0-g37228af) was used to perform realignment around potential indel
sites and base quality score recalibration using the known SNP variation available at the Broad
Institute (https://www.broadinstitute.org/ftp/pub/vgb/dog/trackHub/canFam3/variation). Dual
algorithms, Samtools mpileup (version samtools-1.2) and GATK haplotype caller module were
used to detect variants and the variants from both algorithms were merged into variant call for-
mat (VCFv4.1). Annovar and SnpEff tools were used to annotate the variants to Ensembl, NCBI
and Broad annotation databases to predict the functional effects of the variants. We identified on
average ~6 million variants per sample and the sequencing coverage varied between 22-49x. The
three affected dogs shared ~1.5 million homozygous variants. Filtering under recessive model
against two carriers and fourteen controls left 2690 homozygous variants in total, of which five
variants were in the predicted coding regions (1 indel, 2 non-synonymous, 1 synonymous).
Genomic DNA analysis
Large numbers of dogs were genotyped for the identified variants using various protocols. Gen-
otyping of individual dogs for the CMO variant was performed either by TaqMan assay
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(Applied Biosystems) or by sequencing a 786-bp PCR product using a forward primer (5-GGC
TCCAGTCTAAGCCAGGT-3) and a reverse primer (5-AAGGAGTGCGCTCAAGACAG-3)
flanking the SLC37A2 SNP. The PCR products were amplified with AmpliTaqGold360Master-
mix (Life Technologies), and the products were directly sequenced using the PCR primers on
an ABI 3730 capillary sequencer (Life Technologies) after treatment with exonuclease I (New
England Biolabs) and rapid alkaline phosphatase (Roche). The sequence data were analyzed
using Sequencher 5.1 (GeneCodes). Potential exonic splice enhancer (ESE) motifs were
detected with ESEfinder 3.0 [46, 47].
Pathogenicity of the FAM20C c.899C>T variant was evaluated using web-based bioinfor-
matic prediction tools SIFT [48] and PolyPhen-2 (genetics.bwh.harvard.edu/pph2) [49] was
applied to evaluate the pathogenic effect of the mutation. SIFT score ranges from 0 to 1. The
amino acid substitution is predicted to be damaging if the score is smaller than 0.05. PolyPhen-
2 score ranges from 0 to 1. The amino acid substitution is predicted to be damaging if the score
is bigger than 0.85.
Genotyping of FAM20C and SCARF2 variants was performed by standard PCR with the fol-
lowing primers: FAM20C: 5-GCTTCTATGGCGAGTGTTCC-3 and 5-CCGGGATGTCTGA
GTAAGGA-3; SCARF2:5-CAATCCCCGAGTGCTCTCC-3 and 5-AGGAAACTGCCCCCA
AAGAG-3.
Transcript analysis
Expression analyses were performed for the CMO and VDEGS projects. Blood samples were
collected into PAXgene tubes (PreAnalytix) and RNA was isolated using PAXgene Blood RNA
Kit (Qiagen). The cDNA synthesis was performed using SuperScriptIII enzyme (Invitrogen)
with an oligo d(T)24V primer according to manufacturer’s instructions. To investigate possible
aberrant splicing events, we amplified cDNAs from the junction of exons 7 and 8 to the junc-
tion of exons 17 and 18 of the SLC37A2 gene (810 bp) using SequalPrep Long Polymerase
(Invitrogen) with a forward primer GAATACCCAGAAGACGTGGAC and a reverse primer
CCTCTGTCTCTGTTCAGGAATG in 16 WHWTs. B2M was used as a loading control. The
identity of the amplicons was confirmed by Sanger sequencing. In the VDEGS project, the pos-
sible effect of the 2-bp deletion on the stability of the SCARF2 transcript was investigated by
RT-PCR. Total RNAs were isolated from skin samples from one affected and unaffected dog
obtained in the postmortem autopsies. The cDNA synthesis was performed as described above.
Forward 5-CAACCACGTCACTGGCAAGT-3 and reverse 5-TTACAGTGGGG CCCGTG
G-3 primers were designed to amplify a 188-bp region between exon 6 and exon 8 of SLC37A2.
Semi-quantitative analysis of the expression was determined and visualized by electrophoresis.
Histological examination of teeth
Permanent and deciduous incisor and premolar teeth were removed for therapeutic reasons
from two Border Collie bitches with clinically affected teeth. The dogs were from the same lit-
ter. Three teeth, two incisors and one premolar, were obtained from one dog. One incisor and
the premolar were processed to ground sections and the other incisor to paraffin sections.
From the other dog, four teeth, two incisors and two premolars, were obtained. One incisor
and one premolar were processed to ground sections and the other incisor and the other pre-
molar to paraffin sections. For comparison, deciduous teeth obtained from a healthy Border
Collie were studied. One incisor was processed to ground sections and one tooth to paraffin
sections. The teeth to be processed to ground sections (a procedure preserving the enamel with
a proportionally high mineral content and sparse organic matrix) were fixed with 10% neutral
buffered formalin, dehydrated and embedded in liquid methylmethacrylate monomer. After
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complete polymerization, started up by benzoylperoxide (2 g/l), the teeth were serially cut to
100–150 μm thick longitudinal sections with a rotating diamond-coated saw microtome, let
dry and mounted unstained with DePex (Gurr, BDH, Poole, UK). For preparation to paraffin
sections, the teeth were fixed with formalin, demineralized with EDTA (0.33 mol/l, pH 7.2),
which leads to the loss of the enamel, and embedded in paraffin. A representative series of sec-
tions were longitudinally cut at 7 μm and stained with haematoxylin and eosin (HE).
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